COVID cases are continuing to decline in the U.S., however we are beginning to see some increased activity with new variants, particularly BQ.1 and BQ.1.1.
Key Points: COVID In today’s Recommendation for Industry, we discuss the globally increasing respiratory diseases, which we see as likely attributable to annual seasonal trends.
Key Points: COVID In today’s Recommendation for Industry, we discuss the return of norovirus and its spread through insufficient handwashing. Read more below. COVID booster
Key Points: COVID In today’s Recommendation for Industry, we discuss the typical increase of respiratory disease in the fall and how to prepare now. Read
Key Points: In today’s Recommendation for Industry, we discuss the possibility of COVID transmission from packaging. Read more below. Nitric oxide boosts oxygen in pregnant
Key Points: In today’s Recommendation for Industry, we provide updates on COVID-19 and Monkeypox. Read more below. Pfizer’s Omicron-Targeting COVID-19 Vaccines Generate Stronger Immune Response.
Key Points: In today’s Recommendation for Industry, we discuss the low risk of monkeypox in the US, and what businesses can do to keep it
Key Points: In today’s Recommendation for Industry, we discuss the current data on COVID case rates and hospitalizations. Read more below. FDA committee approves Moderna
Key Points: In today’s Recommendation for Industry, we discuss the recent monkeypox outbreak. Read more below. In-utero COVID exposure tied to language, motor delays by
Key Points: In today’s Recommendation for Industry, we discuss defending against infectious disease. Read more below. COVID-19 vaccine during pregnancy may protect infants. The COVID-19
